Verastem Inc. to Participate in Cantor Global Healthcare Conference 2025

Reuters
2025.08.27 11:00
portai
I'm PortAI, I can summarize articles.

Verastem Inc., a biopharmaceutical company focused on RAS/MAPK pathway-driven cancers, will participate in the Cantor Global Healthcare Conference 2025. The management team is scheduled to present during a fireside chat on September 3 at 3:55 pm ET. This announcement was generated by Public Technologies and is for informational purposes only.

Verastem Inc., a biopharmaceutical company focused on developing treatments for RAS/MAPK pathway-driven cancers, is set to participate in the Cantor Global Healthcare Conference 2025. The company’s management team will present during a fireside chat on Wednesday, September 3, at 3:55 pm ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verastem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250827486598) on August 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.